David Allsop

15.5k citations

148 papers · 12.2k indexed · 4 hit papers · h-index 51

Impact in

Physiology top 0.1%
- Alzheimer's disease research and treatments
Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Physiology 99
- Alzheimer's disease research and treatments 98
Neurology 34
- Parkinson's Disease Mechanisms and Treatments 27
- Neurological disorders and treatments 9
- Neurological diseases and metabolism 8

Co-authors: John Hardy Omar M. A. El‐Agnaf Brian J. Tabner David M. A. Mann Katerina E. Paleologou Penelope G. Foulds Stuart Turnbull Shu‐ichi Ikeda
Journals: Biochemical Society Transactions (10 papers)PLoS ONE (6 papers)Scientific Reports (5 papers)Acta Neuropathologica (5 papers)Neurobiology of Aging (5 papers)
Partner nations: United Kingdom Japan United States

In The Last Decade

David Allsop

147 papers receiving 11.9k citations

Hit Papers

align trajectories log scale

Magnetite pollution nanoparticles in the human brain 2016 · 749 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Proceedings of the National Academy of Sciences
2006 The FASEB Journal
1997 Nature Medicine
1991 Trends in Pharmacological Sciences

Peers

Replace David M. A. Mann with:

David M. A. Mann United Kingdom

Kevin J. Barnham Australia

Dean M. Hartley United States

Robert A. Cherny Australia

Jorge R. Barrio United States

Shun Shimohama Japan

Daniel P. Perl United States

Bengt Långström Sweden

Fiona Crawford United States

Akihiko Nunomura Japan

David Allsop relative to David M. A. Mann United Kingdom David M. A. Mann's profile →

Citations per field

00.5×1.5×

David M. A. Mann · 1×

×0.9 7k/8k

PHYSI

×0.8 3k/4k

NEURO

×0.6 2k/3k

NEURO

×1.1 334/312

BP

×0.6 2k/3k

CMN

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by David Allsop

Since Specialization

Citations

This map shows the geographic impact of David Allsop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Allsop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Allsop more than expected).

Fields of papers citing papers by David Allsop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Allsop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Allsop. The network helps show where David Allsop may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Allsop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Allsop Line = papers co-authored together David Allsop links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics PLoS ONE ·Yuta Kojima, Takashi Kasai, Yu‐ichi Noto, Takuma Ohmichi, Harutsugu Tatebe, Heather H. Roberts, Yukiko Tsuji, Aderemi Aderoju, Zhang Keying Liu Yuhong, David Allsop, Satoshi Teramukai, Toshiki Mizuno, Takahiko Tokuda	2021	19
2	Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's disease The Analyst ·Maria Paraskevaidi, Camilo L. M. Morais, H. LITHWICK, Kássio M. G. Lima, David M. A. Mann, David Allsop, Pierre L. Martin‐Hirsch, Francis L. Martin	2018	27
3	α-Synuclein Interacts with Lipoproteins in Plasma Journal of Molecular Neuroscience ·Fatemeh Nouri Emamzadeh, David Allsop	2017	25
4	Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide Nanomedicine Nanotechnology Biology and Medicine ·Maria Gregori, Mark Taylor, Elisa Salvati, Francesca Re, Simona Mancini, Claudia Balducci, Gianluigi Forloni, Vanessa Zambelli, Silvia Sesana, Maria Michael, Okitsugu Yamashita, Т.Г. Максимова, Oleg Kolosov, Michael A. Sherer, Stephen Harris, Nigel J. Fullwood, Massimo Masserini, David Allsop	2016	46
5	Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users International Journal of Legal Medicine ·John H. Lewis, Anna Molnár, David Allsop, Jan Copeland, Shanlin Fu	2015	3
6	Characteristics of Iranian Women Seeking Drug Treatment Journal of Women s Health ·Kate Dolan, Shabnam Salimi, Bijan Nassirimanesh, J. W. Graham, David Allsop, Azarakhsh Mokri	2011	37
7	Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies Neurobiology of Disease ·Penelope G. Foulds, Osamu Yokota, Andrew Thurston, Yvonne S. Davidson, Zubair Ahmed, Janice L. Holton, J. C. Thompson, Haruhiko Akiyama, Tetsuaki Arai, Masato Hasegawa, Alexander Gerhard, David Allsop, David M. A. Mann	2011	79
8	TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration Acta Neuropathologica ·Penelope G. Foulds, Ammara Ahmad, Linda Gibbons, Yvonne S. Davidson, Stuart Pickering‐Brown, David Neary, Julie S. Snowden, David Allsop, David Mann	2008	125
9	Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease Biochemical and Biophysical Research Communications ·Takahiko Tokuda, Regina Mohan, David Allsop, Toshiki Mizuno, Masanori Nakagawa, A.J. Martínez-Ortega, Joseph J. Locascio, Michael G. Schlossmacher, Omar M. A. El‐Agnaf	2006	346
10	Protein aggregation, metals and oxidative stress in neurodegenerative diseases Biochemical Society Transactions ·Omar M. A. El‐Agnaf, Brian J. Tabner, Matthew J. German, Nigel J. Fullwood, David Allsop	2005	81
11	α-Synuclein and the Pathogenesis of Parkinsons Disease Protein and Peptide Letters ·Francis L. Martin, Marie-Rose Aurembou, Katerina E. Paleologou, David Allsop, Omar M. A. El‐Agnaf	2004	27
12	Introduction to Alzheimer's Disease Humana Press eBooks ·David Allsop	2003	8
13	Fe(II)‐induced DNA damage in α‐synuclein‐transfected human dopaminergic BE(2)‐M17 neuroblastoma cells: detection by the Comet assay Journal of Neurochemistry ·Francis L. Martin, Marie-Rose Aurembou, Katerina E. Paleologou, Rebecca Hewitt, Omar M. A. El‐Agnaf, David Allsop	2003	37
14	Gelatinase A not α-secretase? Lancaster EPrints (Lancaster University) ·Dominic M. Walsh, C. H. Williams, Giovanny Almache Eguez, David Allsop, Gillian Murphy	1994	1
15	Secretory Form of Alzheimer Amyloid Precursor Protein 695 in Human Brain Lacks β/A4 Amyloid Immunoreactivity Biochemical and Biophysical Research Communications ·Fuyuki Kametani, Kunihito Tanaka, Tsuyoshi Ishii, Mamdouh A Elsherif, Giovanny Almache Eguez, David Allsop	1993	37
16	Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type Neuroscience Letters ·Stephen M. Gentleman, Ben Williams, M.C. Royston, Carol Craig, Joanne Clinton, R. H. Perry, Paul G. Ince, David Allsop, Julia M. Polak, Gareth W. Roberts	1992	23
17	Immunohistochemical and immunoelectron microscopical characterization of cerebrovascular and senile plaque amyloid in aged dogs' brains Brain Research ·Tokuhiro Ishihara, Toshikazu Gondo, Everardo A. Ocampo P., Fumiya Uchino, Shu‐ichi Ikeda, David Allsop, Kohzoh Imai	1991	44
18	Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy Human Pathology ·Shu‐ichi Ikeda, Nobuo Yanagisawa, David Allsop, George G. Glenner	1990	37
19	The occult aftermath of boxing. Journal of Neurology Neurosurgery & Psychiatry ·G.W. Roberts, David Allsop, C.J. Bruton	1990	364
20	The histochemical location of three diagnostic enzymes in the marmoset liver Journal of Applied Toxicology ·Xian Hua Yao, 이승찬, Iris J. E. Renken, David Allsop, David Eichler, Japan P A Clarkson, John M. Walker	1989	1

About David Allsop

David Allsop is a scholar working on Physiology, Neurology, Neurology, Pharmacology and Biophysics, having authored 148 papers that have together received 12.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (98 papers), Parkinson's Disease Mechanisms and Treatments (27 papers), Prion Diseases and Protein Misfolding (22 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Computational Drug Discovery Methods (13 papers), Neurological disorders and treatments (9 papers), Supramolecular Self-Assembly in Materials (9 papers) and Neurological diseases and metabolism (8 papers). The work is most often cited by research in Physiology (6.7k citations), Neurology (3.4k citations), Neurology (1.6k citations), Biological Psychiatry (334 citations) and Cellular and Molecular Neuroscience (1.8k citations). David Allsop has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include John Hardy, Omar M. A. El‐Agnaf, Brian J. Tabner, David M. A. Mann, Katerina E. Paleologou, Penelope G. Foulds, Stuart Turnbull, Shu‐ichi Ikeda, Nigel J. Fullwood and G.W. Roberts. Their work appears in journals such as Biochemical Society Transactions, PLoS ONE, Scientific Reports, Acta Neuropathologica and Neurobiology of Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact